10-Q: Jushi Holdings Reports Q1 2026 Results, Refinances Debt

Jushi Holdings Inc. reported a 4% increase in net revenue for Q1 2026, driven by retail and wholesale growth, alongside a significant debt refinancing.

Summary

• Jushi Holdings Inc. reported net revenue of $66.4 million for the first quarter ended March 31, 2026, a 4% increase from $63.8 million in the same period last year.
• Gross profit increased by 16% to $29.9 million, with a gross profit margin improving to 45% from 40% in Q1 2025.
• Operating expenses rose slightly by 2% to $28.3 million.
• The company reported a net loss of $19.8 million ($0.10 per share) for the quarter, compared to a net loss of $17.0 million ($0.09 per share) in Q1 2025.
• Adjusted EBITDA increased by 16% to $11.4 million from $9.8 million in the prior year's quarter.
• The company successfully refinanced its 2024 Term Loan and Second Lien Notes, issuing a new $160 million senior secured term loan (2026 Term Loan) maturing in March 2029.
• Cash and cash equivalents increased to $39.7 million as of March 31, 2026, from $24.0 million as of December 31, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as cautiously negative due to the widening net loss and ongoing retail market pressures, despite positive operational improvements like increased gross margins and Adjusted EBITDA, and a significant debt refinancing.

Positives

• Revenue increased by 4% to $66.4 million, driven by a 2% rise in retail revenue and a significant 22% increase in wholesale revenue.
• Gross profit margin improved to 45% from 40%, indicating better cost management and operational efficiency.
• Adjusted EBITDA grew by 16% to $11.4 million, demonstrating improved underlying operational profitability.
• Successful refinancing of significant debt obligations (2024 Term Loan and Second Lien Notes) into a new $160 million term loan with a later maturity date (March 2029) improves near-term liquidity.
• Cash and cash equivalents saw a substantial increase, rising from $24.0 million to $39.7 million, strengthening the company's liquidity position.
• The company ended the quarter with 42 dispensaries in 8 states, an increase from 40 dispensaries in 7 states in the prior year, indicating expansion.
• Jushi branded product sales as a percentage of retail revenue increased to 58% from 56%, suggesting growing brand recognition and customer loyalty.

Negatives

• Net loss widened to $19.8 million from $17.0 million in the prior year's quarter.
• Loss per share increased to $0.10 from $0.09.
• Despite revenue growth, several key retail markets (Illinois, Pennsylvania, Massachusetts, Nevada) experienced sales declines due to increased competition and pricing pressures.
• The company faces significant ongoing legal proceedings, including the MJs Market Matter and the Sammartino Matter, which could result in substantial damages or settlements.
• The company's operations are subject to the evolving and uncertain regulatory landscape of the cannabis industry, particularly concerning federal law and potential tax implications under Section 280E.

Risks

• Continued pricing pressure and increased competition in key retail markets may adversely impact future revenue and profitability.
• The company's operations are subject to U.S. federal law, which still classifies cannabis as a Schedule I controlled substance, posing risks of federal enforcement actions, fines, and asset forfeiture.
• The company is involved in ongoing litigation (MJs Market Matter, Sammartino Matter, Pacific Collective Matter) which could lead to significant financial liabilities and reputational damage.
• Changes in U.S. federal and state cannabis regulations, including the interpretation and application of Section 280E of the Internal Revenue Code, could materially affect financial results.
• The proposed continuance of the company from British Columbia to Nevada may not be completed or may not yield the anticipated benefits.
• The company's ability to continue as a going concern is mentioned as a risk factor in the cautionary note, highlighting potential liquidity challenges.
• Reliance on key inputs, suppliers, and skilled labor, as well as potential supply chain disruptions, could impact operations.
• The company's significant indebtedness, including the new 2026 Term Loan, presents ongoing interest expense and potential covenant compliance risks.

Future Outlook

The company believes its existing cash and cash equivalents, along with cash from operations, will be sufficient to meet working capital and capital expenditure needs for at least the next twelve months. They may consider opportunistic capital raising or refinancing transactions. The transition to adult-use sales in Virginia is expected to expand the customer base and increase demand, though the extent and timing remain uncertain. The federal rescheduling of certain cannabis products to Schedule III is being evaluated for its potential impact on business, including tax treatment, but benefits are uncertain.

Management Comments

• The company believes the continuance from British Columbia to Nevada will enhance shareholder value by better aligning its corporate structure with its operations and allowing for more efficient operations.
• Management is evaluating the potential impact of the U.S. Department of Justice's reclassification of certain cannabis products to Schedule III, including implications for federal income tax treatment under Section 280E.
• The transition to adult-use sales in Virginia is expected to present a potential opportunity for revenue growth, though the extent and timing remain uncertain.
• Management believes the company is in material compliance with applicable local and state regulations, but acknowledges the evolving nature of marijuana regulations and potential for differing interpretations.

Industry Context

StockSavvy.ai notes that Jushi Holdings Inc.'s Q1 2026 results reflect the ongoing challenges and opportunities within the U.S. cannabis sector. The revenue growth, particularly in wholesale, and improved gross margins are positive signs, but the widening net loss and continued retail market pressures highlight the intense competition and pricing compression prevalent in the industry. The significant debt refinancing is a crucial step in managing financial obligations, while the federal rescheduling of cannabis to Schedule III presents a complex but potentially beneficial shift in the regulatory landscape, particularly regarding tax implications under Section 280E.

Comparison to Industry Standards

• Jushi's gross profit margin of 45% is a positive indicator compared to the general industry average, which can fluctuate significantly but often hovers in the 30-50% range depending on market maturity and operational efficiency.
• The company's Adjusted EBITDA of $11.4 million for the quarter shows a positive trend, indicating a move towards profitability, a key metric for investors in the cannabis sector which is still largely unprofitable at the net income level.
• The net loss of $19.8 million, while a negative, is not uncommon in the capital-intensive and highly regulated cannabis industry, where many operators are still investing heavily in growth and facing significant operational costs and tax burdens (like Section 280E).
• The debt refinancing, while necessary, highlights the capital needs of multi-state operators (MSOs) in the U.S. cannabis market, which often rely on debt financing due to federal restrictions on equity markets and banking access.

Legal Proceedings

• MJs Market Matter: Complaint filed in federal district court in Massachusetts alleging violations of antitrust and consumer protection acts related to the Nature's Remedy of Massachusetts transaction. Court denied defendants' motion to dismiss; parties are in discovery.
• Sammartino Matter: Dispute with former owner of Nature's Remedy regarding alleged breaches of a purchase agreement and fraudulent inducement, leading to claims and counterclaims regarding promissory notes and share issuances.
• Pacific Collective Matter: Complaint filed in California state court alleging breach of a commercial property lease and lease guaranty, seeking over $20,000 in damages. The company believes it lawfully rescinded the lease; an appeal by Pacific Collective remains pending.

Related Party Transactions

• Participation in the 2026 Term Loan by Serpentine Capital Management III, LLC (controlled by CEO James Cacioppo) with a principal amount of $27,993.
• Participation in the 2026 Term Loan by Denis Arsenault (founder and significant equity holder) with a principal amount of $21,016.
• Prior debt obligations (Second Lien Notes and 2024 Term Loan) included amounts related to the CEO and a significant investor, which were settled in March 2026.

Stakeholder Impact

• Shareholders: Potential dilution from future capital raises, impact of legal proceedings, and uncertainty surrounding the proposed corporate continuance. Positive impact from improved operational metrics and debt refinancing.
• Creditors: The debt refinancing addresses near-term maturity concerns, but the company's significant debt load remains a factor.
• Employees: Increased employee costs due to expanded operations and new store openings.
• Suppliers: Potential impact from supply chain disruptions or changes in demand due to market conditions.
• Customers: Continued availability of Jushi branded products and competitive pricing across retail locations.

Next Steps

• Seek shareholder approval for the proposed arrangement involving the continuance from British Columbia to Nevada.
• Continue to evaluate the potential impact of federal cannabis rescheduling to Schedule III on business operations and tax treatment.
• Monitor the outcome of adult-use cannabis legislation in Virginia.
• Continue to manage debt obligations and compliance with financial covenants.
• Pursue opportunistic capital raising or refinancing transactions if needed.

Key Dates

Recommendation

The company shows operational improvements with increased revenue, gross margin, and Adjusted EBITDA, alongside a successful debt refinancing that improves liquidity. However, the widening net loss, ongoing retail market pressures in key states, and significant legal risks present substantial headwinds. The potential benefits from federal cannabis rescheduling are still uncertain. Therefore, a 'hold' recommendation is appropriate, pending clearer signs of sustained profitability and resolution of legal challenges.

Keywords

Jushi Holdings Inc., Form 10-Q, Quarterly Report, Cannabis Industry, Multi-state Operator, Revenue, Net Loss, Adjusted EBITDA, Debt Refinancing, 2026 Term Loan, SEC Filing, Financial Statements, Market Risk, Legal Proceedings, Regulatory Environment, Section 280E